AliveCor Logo

Unsere Produkte

Kardia 12L

Neu

KardiaMobile 6L
InstantQT
KardiaPro
Kardia-EKG-Geräte

Unsere Lösungen

Screening für Vorhofflimmern
Datenintegrationslösungen
Gesundheitsdienstleister
BioPharma

Info

Führung
Mission
Klinische Forschung
Unsere Partner
Pressemitteilungen
Alle Produkte entdecken
Ressourcenzentrum
Kontakt
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • Mission
    • Führung
    • Forschung
    • Stellenangebote
    • Pressemitteilungen
    • Ressourcenzentrum
    • FAQs
    • Benutzerhandbücher
    • Versand
    • Garantie
    • Partner
    • Integration
  • Kardia by AliveCor
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
    • Plan zur Kohlendioxidreduzierung
    • Erklärung zu moderner Sklaverei
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Datenschutzrichtlinie
  • Sicherheit
  • Einwilligung für Telemedizin
  • Bedingungen
  • Barrierefreiheit

©2024 AliveCor, Inc. Alle Rechte vorbehalten. Patente www.alivecor.com/patents. AliveCor und Kardia sind Marken von AliveCor, Inc. in den USA und anderen Ländern. Apple ist eine in den USA und anderen Ländern eingetragene Marke von Apple, Inc. App Store ist eine Dienstleistungsmarke von Apple, Inc. Android ist eine Marke von Google Inc. Google Play ist eine Marke von Google Inc.

ZURÜCK
AliveCor Launches New Feature to Enhance Visual Quality of ECG
SAN FRANCISCO Calif., 23. August 2013

Now Available Through the AliveECG App

AliveCor, Inc. announced today the release of a new AliveECG App for its Heart Monitor that features an Enhanced Filter, a noise cancelling technology that improves the visual output of the ECG. The AliveCor Heart Monitor is a mobile device-based ECG monitor for the iPhone 4, 4S, and 5 that is used to record, display, store and transfer single-channel electrocardiogram (ECG) rhythms.

The Enhanced Filter aids in the reduction of noise commonly caused by the environment and/or by muscular vibrations that can result in non-readable or difficult to read rhythm strips. This major advancement improves visual quality and enables efficient interpretation. Ability to clearly delineate between normal sinus rhythm and arrhythmia is of utmost importance to both the physician and patient for proper treatment and management.

“The new technology makes it easier for patients using the device to record and send cleaner ECGs. This makes it easier and more efficient for me to diagnose the problem,” said Dr. Jeffery Olgin, Chief of Cardiology, University of California, San Francisco.

The new AliveECG App also features an improved menu that allows for easy navigation. Patients are able to annotate each ECG recording quickly by tapping on the current symptoms and/or activities. Tracking activities and symptoms provides greater context in which to interpret the ECG recording and can aid in the identification of arrhythmia triggers.

“AliveCor’s vision is to provide medical professionals and patients with cost effective quality solutions that deliver superior clinical utility,” said Euan Thomson, AliveCor CEO and President. “We have a robust product pipeline and plan to introduce new features, products, and services on a regular basis to further our vision.”

AliveCor’s Heart Monitor snaps onto the back of an iPhone to record, display, store, and transfer single-channel electrocardiogram (ECG) rhythms wirelessly with the corresponding, free AliveECG app. The Heart Monitor is FDA cleared and CE marked and makes ECG data accessible anytime, anywhere.

Lassen Sie uns gemeinsam die kardiovaskuläre Versorgung transformieren

Kontaktieren Sie uns, wenn Sie ein Arbeitgeber oder Kostenträger sind, der nach einer umfassenden Lösung für die Herzgesundheit sucht.